CarrTech


Developer of an integrated filter-and-needle medical device intended to remove glass particulates from medications drawn from glass ampoules. The company pursued regulatory clearance and testing, secured investment and grants, holds multiple patents, and has conducted human factors studies to validate usability for healthcare settings. The founder is a pharmacist with clinical and hospital experience.

Industries

Health Care
Medical Device
Biotechnology Research

Nr. of Employees

small (1-50)

CarrTech

Frederick, Maryland, United States, North America


Patents

Filtering needle assembly with seal plug

US-11857768-B1

View Details

Filtering needle cap with a seal around a needle

US-10512728-B2

View Details

Filtering needle cap having a sleeve sealing around a needle

US-9669164-B2

View Details

Filter needle

US-8002751-B2

View Details

Products

FROG (all-in-one filter and hypodermic needle device)

A single-unit device that combines a filtration element and a hypodermic needle to filter glass particulates from medications drawn from glass ampoules during preparation.

FROG®

FROG® (Filter Removal of Glass) is the first and only FDA-cleared all-in-one device that combines a filter and hypodermic needle in a single package.


Services

Iterative design, prototyping, and development support to advance a medical device toward regulatory submission and manufacturing readiness.

Conducting structured human factors studies with healthcare professionals to assess usability and preference for device-based medication preparation workflows.

Expertise Areas

  • Medical device development
  • Device regulatory clearance (FDA 510(k))
  • Human factors and usability testing
  • Medication preparation safety and risk mitigation
  • Show More (2)

Key Technologies

  • Integrated filtration mechanisms for injectable medications
  • Filter-needle integration for ampoule preparation
  • Human factors evaluation methodologies
  • Medical device prototyping and iterative build processes
  • Show More (1)

News & Updates

A 10-day human factors study with 22 healthcare participants reported 100% of participants preferring the device over current methods.

Company announcement celebrating receipt of FDA 510(k) Class II clearance for the integrated filter-and-needle device.

Coverage noting the company's seed fundraising activities led by venture investment.

Regulatory clearance for the integrated filter-and-needle medical device (FDA 510(k) Class II).

Selected as Maryland Tech Council’s 2021 Emerging Life Sciences Company of the Year.

Seed / venture investment announced to support product development, sales, and marketing.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.